J&J and Protagonist Therapeutics’ Oral Psoriasis Drug Shows Positive Results in Phase 3 Trial

November 24, 2024

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

October 10, 2026

Selecta and Cartesian strengthen funding for the objectives of autoimmune cell treatment in reverse merger

November 13, 2023

Must Read

Top 10 Digital Capabilities Separating Industry Leaders

October 29, 2026

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

October 29, 2026

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

October 29, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

Novartis Reports Late-Stage Trial Setbacks for Del-Desiran and Pelacarsen

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

BMS Reports Positive Phase 3 Results for Iza-Bren in Lung and Breast Cancer

BioNTech Reports Modest Benefit and Safety Concerns in Phase 3 Breast Cancer Trial

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Top 10 Digital Capabilities Separating Industry Leaders

Top 10 Metrics Clinical Operations Leaders Should Track

Real-Time Commercial Intelligence in Life Sciences

Top 10 AI Skills Every Life Sciences Leader Needs

Insights

Surprising Things Your Walk Can Say About You

Editor Picks

J&J and Protagonist Therapeutics’ Oral Psoriasis Drug Shows Positive Results in Phase 3 Trial

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Selecta and Cartesian strengthen funding for the objectives of autoimmune cell treatment in reverse merger

Must Read

Top 10 Digital Capabilities Separating Industry Leaders

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Hot Topics

About Us

Follow Us